Background: Disease-specific quality of life instruments assess the impact of chronic rhinosinusitis on patients' quality of life (QoL). To the extent of our knowledge, there are no Arabic versions of two instruments-the Rhinosinusitis Disability Index (RSDI) and the Chronic Sinusitis Survey (CSS).
Objective: Develop an Arabic-validated version of both instruments, thus allowing its use among the Arabic population.
Design: Prospective cross-sectional study for instrument validation.
Setting: Tertiary university hospital.
Subjects And Methods: This study was conducted between September 2015 and October 2016. We followed the international comprehensive guidelines for translation and cross-cultural adaptation of QoL instruments.
Main Outcome Measures: Test-retest reliability, discriminant validity, and responsiveness ability of both the RSDI and CSS Arabic versions.
Sample Size: 124.
Results: The sample comprised 75 patients diagnosed with chronic rhinosinusitis and 49 healthy control subjects. The Arabic version of both instruments showed high internal consistency (Cronbach's alpha: RSDI=0.97, CSS=.88) and the ability to differentiate between diseased and healthy volunteers (P less than .0001). The translated versions also detected significant change in response to an intervention (P less than .0001).
Conclusion: These Arabic validated versions of the RSDI and CSS can be used for both clinical and research purposes.
Limitations: This study was performed in only one tertiary hospital.
Conflict Of Interest: None.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074302 | PMC |
http://dx.doi.org/10.5144/0256-4947.2018.159 | DOI Listing |
Cochrane Database Syst Rev
January 2025
Department of Otorhinolaryngology, Amsterdam University Medical Centre, Amsterdam, Netherlands.
Background: NSAID-exacerbated respiratory disease (N-ERD) is a hypersensitivity to non-steroidal anti-inflammatory drugs (NSAIDs), such as aspirin or ibuprofen, accompanied by chronic rhinosinusitis (with or without nasal polyps) or asthma. The prevalence of hypersensitivity to NSAIDs is estimated to be 2%. The first line of treatment is the avoidance of NSAIDs.
View Article and Find Full Text PDFCureus
September 2024
Faculty of Medicine, Qassim University, Buraydah, SAU.
Allergic fungal rhinosinusitis (AFRS) is a severe type of chronic rhinosinusitis (CRS) characterized by a high risk of acute vision loss resulting from the affection of optic nerves. This vision loss results from direct pressure upon the optic nerve by the sinus tissues and bone degradation. This is why early involvement of a professional is significant so as not to result in a permanent disability.
View Article and Find Full Text PDFJ Pharm Bioallied Sci
July 2024
Consultant Oral and Maxillofacial Surgeon, Jabalpur, Madhya Pradesh, India.
Objective: To assess how well steroidal nasal sprays and oral steroids work for treating CRS.
Methods: Two hundred patients with CRS were included in a randomized controlled experiment. The patients were split into two groups: Group B received steroidal nasal sprays (fluticasone propionate 110 mcg/day in each nostril for 12 weeks) and Group A received oral steroids (prednisolone 30 mg/day for 14 days, followed by tapering over 7 days).
Laryngoscope
September 2024
Department of Otolaryngology-Head & Neck Surgery, University of North Carolina, Chapel Hill, North Carolina, U.S.A.
Objective: The butterfly graft (BFG) secondary contouring procedure addresses external nasal irregularities following the primary BFG surgery. We explore demographic factors associated with the desire for secondary contouring and assess patient-reported outcomes following the procedure.
Methods: A retrospective analysis of 374 patients undergoing BFG between April 2020 and April 2023 identified 10 individuals electing for secondary contouring.
Indian J Otolaryngol Head Neck Surg
August 2024
RVM Institute of Medical Sciences, Telangana, India.
Introduction: Chronic rhinosinusitis (CRS) is a chronic inflammatory disease of nasal and paranasal sinus mucosa where symptomatology has continued beyond 12 weeks. Manuka honey is made by bees that pollinate the native leptospermum scoparium bush (tea tree). Baby shampoo is a commercially available liquid solution containing multiple chemical surfactants that can act as a mucolytic and an antimicrobial agent.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!